Crossmark

Comparison of the Incidence of Adverse Events Between Japanese and Non-Japanese Healthy Subjects in Phase I Studies: A Systematic Review and Meta-Analysis

Crossref DOI link: https://doi.org/10.1007/s40261-023-01327-x

Published Online: 2023-12-02

Published Print: 2024-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sakurai, Satomi

Matsui, Kazuhiro

Narukawa, Mamoru
License Information

Text and Data Mining valid from 2023-12-02

Version of Record valid from 2023-12-02
More Information

Article History

Accepted: 7 November 2023

First Online: 2 December 2023

Declarations

:

: No funding was received for the preparation of this article.

: Satomi Sakurai, Kazuhiro Matsui, and Mamoru Narukawa have no conflicts of interest that are directly relevant to the content of this article. Satomi Sakurai is an employee of Janssen Pharmaceutical K.K.

: Not applicable.

: Not applicable.

: Not applicable.

: All data generated and/or analyzed during the study are included in this published article and New Drug Application dossiers in Japan.

: Not applicable.

: SS and MN were involved in the study design and data interpretation. KM was involved in the data analysis. SS drafted the original manuscript. MN and KM revised the manuscript drafts. All authors have approved the submitted version of the manuscript and agreed to be accountable for any part of the work.

Document is current

Any future updates will be listed below